BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Manocha S, Dhiman S, Grewal AS, Guarve K. Nanotechnology: An approach to overcome bioavailability challenges of nutraceuticals. Journal of Drug Delivery Science and Technology 2022;72:103418. [DOI: 10.1016/j.jddst.2022.103418] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Gajbhiye A, Das D, Patil S. Co-Crystallization Techniques for Improving Nutraceutical Absorption and Bioavailability. Drugs Modification via Co-crystallization [Working Title] 2023. [DOI: 10.5772/intechopen.109340] [Reference Citation Analysis]
2 Mostafa-Hedeab G, Behairy A, Abd-Elhakim YM, Mohamed AA, Noreldin AE, Dahran N, Gaber RA, Alqahtani LS, Essawi WM, Eskandrani AA, El-Shetry ES. Green Synthesized Zinc Oxide Nanoparticles Using Moringa olifera Ethanolic Extract Lessens Acrylamide-Induced Testicular Damage, Apoptosis, and Steroidogenesis-Related Gene Dysregulation in Adult Rats. Antioxidants (Basel) 2023;12. [PMID: 36829920 DOI: 10.3390/antiox12020361] [Reference Citation Analysis]
3 Otchere E, McKay BM, English MM, Aryee ANA. Current trends in nano-delivery systems for functional foods: a systematic review. PeerJ 2023;11:e14980. [PMID: 36949757 DOI: 10.7717/peerj.14980] [Reference Citation Analysis]
4 Memar MY, Dalir Abdolahinia E, Yekani M, Kouhsoltani M, Sharifi S, Maleki Dizaj S. Preparation of rutin-loaded mesoporous silica nanoparticles and evaluation of its physicochemical, anticancer, and antibacterial properties. Mol Biol Rep 2023;50:203-13. [PMID: 36319783 DOI: 10.1007/s11033-022-07953-6] [Reference Citation Analysis]
5 Travica N, Teasdale S, Marx W. Nutraceuticals in mood disorders: current knowledge and future directions. Curr Opin Psychiatry 2023;36:54-9. [PMID: 36044293 DOI: 10.1097/YCO.0000000000000826] [Reference Citation Analysis]
6 Chen JYS, Chua D, Lim CO, Ho WX, Tan NS. Lessons on Drug Development: A Literature Review of Challenges Faced in Nonalcoholic Fatty Liver Disease (NAFLD) Clinical Trials. Int J Mol Sci 2022;24. [PMID: 36613602 DOI: 10.3390/ijms24010158] [Reference Citation Analysis]